Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer.
Russo GI, Musso N, Lo Giudice A, Asmundo MG, Di Mauro M, Bonacci PG, Massimino M, Bivona D, Stefani S, Pricoco E, Ferro M, Camarda M, Cimino S, Morgia G, Caltabiano R, Broggi G. Russo GI, et al. Among authors: ferro m. J Cancer Res Clin Oncol. 2023 Jul;149(7):3681-3690. doi: 10.1007/s00432-022-04262-0. Epub 2022 Aug 16. J Cancer Res Clin Oncol. 2023. PMID: 35972693 Free PMC article.
Comparison Between 64Cu-PSMA-617 PET/CT and 18F-Choline PET/CT Imaging in Early Diagnosis of Prostate Cancer Biochemical Recurrence.
Cantiello F, Crocerossa F, Russo GI, Gangemi V, Ferro M, Vartolomei MD, Lucarelli G, Mirabelli M, Scafuro C, Ucciero G, De Cobelli O, Morgia G, Damiano R, Cascini GL. Cantiello F, et al. Among authors: ferro m. Clin Genitourin Cancer. 2018 Oct;16(5):385-391. doi: 10.1016/j.clgc.2018.05.014. Epub 2018 Jun 4. Clin Genitourin Cancer. 2018. PMID: 29937067
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
Ferro M, Vartolomei MD, Cantiello F, Lucarelli G, Di Stasi SM, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Verze P, Battaglia M, Serretta V, Russo GI, Morgia G, Musi G, de Cobelli O, Mirone V, Shariat SF. Ferro M, et al. Urol Int. 2018;101(1):7-15. doi: 10.1159/000490765. Epub 2018 Jul 4. Urol Int. 2018. PMID: 29975950
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
Ferro M, Vartolomei MD, Russo GI, Cantiello F, Farhan ARA, Terracciano D, Cimmino A, Di Stasi S, Musi G, Hurle R, Serretta V, Busetto GM, De Berardinis E, Cioffi A, Perdonà S, Borghesi M, Schiavina R, Cozzi G, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Crisan N, Muto M, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Shariat S, Mirone V, Lucarelli G. Ferro M, et al. World J Urol. 2019 Mar;37(3):507-514. doi: 10.1007/s00345-018-2397-1. Epub 2018 Jul 10. World J Urol. 2019. PMID: 29992381
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.
Vartolomei MD, Ferro M, Cantiello F, Lucarelli G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdona S, Verze P, La Rocca R, Borghesi M, Schiavina R, Brunocilla E, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Battaglia M, Serretta V, Russo GI, Morgia G, Terracciano D, Musi G, de Cobelli O, Mirone V, Shariat SF. Vartolomei MD, et al. Among authors: ferro m. Clin Genitourin Cancer. 2018 Dec;16(6):445-452. doi: 10.1016/j.clgc.2018.07.003. Epub 2018 Jul 6. Clin Genitourin Cancer. 2018. PMID: 30077463
High-throughput detection of low abundance sialylated glycoproteins in human serum by TiO2 enrichment and targeted LC-MS/MS analysis: application to a prostate cancer sample set.
Gabriele C, Cantiello F, Nicastri A, Crocerossa F, Russo GI, Cicione A, Vartolomei MD, Ferro M, Morgia G, Lucarelli G, Cuda G, Damiano R, Gaspari M. Gabriele C, et al. Among authors: ferro m. Anal Bioanal Chem. 2019 Jan;411(3):755-763. doi: 10.1007/s00216-018-1497-5. Epub 2018 Nov 28. Anal Bioanal Chem. 2019. PMID: 30483857
Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis.
Cantiello F, Russo GI, Kaufmann S, Cacciamani G, Crocerossa F, Ferro M, De Cobelli O, Artibani W, Cimino S, Morgia G, Damiano R, Nikolaou K, Kröger N, Stenzl A, Bedke J, Kruck S. Cantiello F, et al. Among authors: ferro m. Prostate Cancer Prostatic Dis. 2019 May;22(2):206-220. doi: 10.1038/s41391-018-0113-2. Epub 2018 Nov 28. Prostate Cancer Prostatic Dis. 2019. PMID: 30487646
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer.
Ferro M, Di Lorenzo G, Buonerba C, Lucarelli G, Russo GI, Cantiello F, Farhan ARA, Di Stasi S, Musi G, Hurle R, Vincenzo S, Busetto GM, De Berardinis E, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Mistretta FA, Crisan N, Terracciano D, Paolo V, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, Muto M, Rocca R, Mirone V, de Cobelli O, Vartolomei MD. Ferro M, et al. J Cancer. 2018 Oct 20;9(22):4250-4254. doi: 10.7150/jca.26129. eCollection 2018. J Cancer. 2018. PMID: 30519326 Free PMC article.
1,296 results